Silence Therapeutics Financial Overview
Silence Therapeutics's market cap is currently €247.64M. The company's EPS TTM is €-0.127875603; its P/E ratio is -3.20; Silence Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €-0.17. See an overview of income statement, balance sheet, and cash flow financials.
